Overview:
Immunotherapy offers the potential for long-term disease control in patients with locally advanced and metastatic non-small cell lung cancer (NSCLC), and more recently, this strategy has been incorporated into the management of early-stage disease. As novel neoadjuvant, adjuvant, and perioperative immunotherapy-based approaches are introduced into the clinical, careful coordination of the multidisciplinary team is essential for timely, effective delivery of these therapies.
This live, hybrid meeting is built to showcase the various treatment considerations for patients with non-metastatic NSCLC in the context of recent approvals, recommendations, and new clinical trial evidence. These discussion will be framed in patient cases highlighting the intricacies of multidisciplinary approaches to evaluation and treatment, with presentations of new data illustrating the efficacy and safety of novel strategies.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Discuss the rationale for applying immunotherapeutic strategies to early-stage and locally advanced NSCLC settings, as well as key considerations in multidisciplinary care coordination between thoracic surgeons, medical oncologists, radiologists, and radiation oncologists
- Design personalized care strategies to integrate evidence with evolving immunotherapy-based approaches to manage patients with resectable stage I-III NSCLC
- Analyze recent data and emerging trends utilizing immune checkpoint inhibitor-based strategies for the management of patients with unresectable stage III NSCLC
- Apply interdisciplinary care strategies for the management of stage I-III NSCLC that include methods to monitor for, identify, and mitigate the impact of irAEs
The 2023 Multidisciplinary Thoracic Cancers Symposium Steering Committee has reviewed and approved this symposium as appropriate for presentation as an Industry Satellite Symposium (ISS). The ISS constitutes the content and views of the sponsor and is not part of the official 2023 Multidisciplinary Thoracic Cancers Symposium program.
Neel Chudgar, MD
Associate Director of Clinical and Translational Research, Thoracic Surgery Attending Physician
Montefiore
Daniel Gomez, MD
Director of Thoracic Radiation Oncology
Memorial Sloan Kettering Cancer Center
David Carbone
Director of the James Thoracic Center
The Ohio State University Medical Center
Jianjun Zhang
Associate Professor
MD Anderson Cancer Center
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.